Indication
Parabolic Flight
1 clinical trial
2 products
Product
DPI-386Product
OtherClinical trial
Optimizing the Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance. Motion Sickness Countermeasures Field TestStatus: Recruiting, Estimated PCD: 2026-09-01